JMAC Enterprises’s iShares US Medical Devices ETF IHI Stock Holding History

JMAC Enterprises’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,071	Closed	-$305K	–	118
2025 Q1	$305K	Sell	5,071 -25	-0.5%	-$1.55K	0.07%	103
2024 Q4	$297K	Hold	5,096	–	–	0.05%	150
2024 Q3	$302K	Sell	5,096 -710	-12%	-$40.5K	0.05%	156
2024 Q2	$325K	Sell	5,806 -81,589	-93%	-$4.57M	0.06%	145
2024 Q1	$5.12M	Buy	87,395 +10,545	+14%	+$596K	0.95%	29
2023 Q4	$4.15M	Buy	76,850 +9,089	+13%	+$444K	0.89%	28
2023 Q3	$3.29M	Buy	67,761 +4,610	+7%	+$245K	0.81%	31
2023 Q2	$3.57M	Buy	63,151 +1,436	+2%	+$79.1K	0.88%	29
2023 Q1	$3.33M	Buy	61,715 +477	+0.8%	+$25.4K	0.85%	30
2022 Q4	$3.22M	Sell	61,238 -2,329	-4%	-$118K	0.89%	28
2022 Q3	$3M	Buy	63,567 +1,404	+2%	+$72.8K	0.84%	30
2022 Q2	$3.14M	Buy	62,163 +2,495	+4%	+$136K	0.81%	29
2022 Q1	$3.64M	Sell	59,668 -181	-0.3%	-$10.8K	0.86%	29
2021 Q4	$3.6M	Buy	+59,849	New	+$3.83M	0.85%	30

Other funds holding IHI

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JMAC Enterprises's IHI Position: Q2 2025 in Review

JMAC Enterprises sold out of iShares US Medical Devices ETF (IHI) in Q2 2025, closing a stake of 5,071 shares — an estimated $305K sold.

JMAC Enterprises first reported a position in IHI in Q4 2021 and held it in 14 quarters. The position peaked at $5.12M in Q1 2024. 547 funds tracked by Wall St. Rank hold IHI as of Q2 2025.

JMAC Enterprises reported no remaining iShares US Medical Devices ETF position as of Q2 2025 after selling out during the quarter.
JMAC Enterprises sold 5,071 iShares US Medical Devices ETF shares in Q2 2025, an estimated $305K.
JMAC Enterprises first reported a position in iShares US Medical Devices ETF in Q4 2021 and held it in 14 quarters.
JMAC Enterprises's iShares US Medical Devices ETF position peaked at $5.12M in Q1 2024.
547 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2025.

Based on JMAC Enterprises's 13F filing for Q2 2025, filed 21 Jul 2025.